Search results
Results From The WOW.Com Content Network
In 1986, Otsuka Holdings Co. Ltd. acquired Ridge Vineyards. In 1990, Otsuka Holdings Co. Ltd. acquired Crystal Geyser Water Company. In 2008, Otsuka Pharmaceutical Co. acquired 49% of Alma S.A., which is the parent company of CG Roxane. In early 2012, Otsuka announced it would focus its "future operations on CNS disorders and oncology".
July 31, 2024 at 9:21 PM. By Rocky Swift. TOKYO (Reuters) -Japan's Otsuka Pharmaceutical said on Thursday it agreed to pay more than $1 billion to acquire Jnana Therapeutics as it looks to expand ...
The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
This listing is limited to those independent companies and subsidiaries notable enough to have their own articles in Wikipedia. Both going concerns and defunct firms are included, as well as firms that were part of the pharmaceutical industry at some time in their existence, provided they were engaged in the production of human (as opposed to veterinary) therapeutics.
(Reuters) -A panel of advisers to the U.S. Food and Drug Administration (FDA) on Tuesday recommended the use of a device made by a unit of Otsuka Holdings in a type of surgery to treat high blood ...
(Reuters) - Japan's Otsuka Holdings said on Tuesday that its experimental drug failed to meet a primary late-stage trial goal in treating agitation associated with dementia due to Alzheimer's disease.
Takeda Midosuji Building, headquarters of Takeda Pharmaceutical Company, in Chuo-ku, Osaka, Japan. Takeda Pharmaceuticals was founded in 1781, and was incorporated on January 29, 1925. [ 12] One of the firm's mainstay drugs is Actos ( pioglitazone ), a compound in the thiazolidinedione class of drugs used in the treatment of type 2 diabetes.
Otsuka Holdings. Website. Taiho Corporate Site (English) Taiho Pharmaceutical Co., Ltd. (大鵬薬品工業, Taihō Yakuhin Kōgyō) is a Japanese pharmaceutical company, and a subsidiary of Otsuka Holdings, which focuses on developing cancer treatments. Taiho, headquartered in Tokyo, Japan, is an R&D -driven specialty pharma focusing on the ...